Trials / Completed
CompletedNCT02586480
Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode
Evolution of the PR Interval in Patients Implanted With a Dual Chamber Pacemaker With Algorithm for Spontaneous AV Conduction Preservation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 848 (actual)
- Sponsor
- LivaNova · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational study on long PR interval using the SafeR mode in bradycardia patients.
Detailed description
This observational trial aims to study the evolution of the PR interval in patients implanted with a dual chamber pacemaker with the SafeR mode. The investigators will assess the prevalence and the incidence of PR lengthening and the investigators will study the long PR interval management by physicians, depending on the data embedded in the pacemaker.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | dual chamber pacemaker with SafeR algorithm | SafeR is an AVB management algorithm: it provides AAI pacing while continuously monitoring AV conduction, it switches to DDD when detecting AVB I, II or III, according to the following criteria: (1) AVB I: 6 long PR intervals, (2) AVB II: 3 blocked atrial events/12 cycles, (3) AVB III: 2 consecutive blocked atrial events. It switches back to AAI mode when needed. |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2015-11-01
- Completion
- 2015-12-01
- First posted
- 2015-10-26
- Last updated
- 2017-10-18
Locations
58 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02586480. Inclusion in this directory is not an endorsement.